Search

everythinglearnresearchcommunity

for

Search:↓

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Injecting a peptide-hyaluronic acid mix improved hair growth in men with hair loss and was safe.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Hyaluronic acid hydrates and benefits skin and hair safely.

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Endocrine therapies for cancer significantly increase the risk of hair loss.

WAA-QOL measures impact of hair loss on women's well-being.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

New acne treatments show promise as alternatives to traditional therapies.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Finasteride may help some women with hair loss, but better options exist.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.